STAT3 and metabolic dysfunction-associated steatotic liver disease: On the other hand, multiple signaling pathways are involved in the progression of NAFLD/NASH, such as JAK/STAT3 [12,13], NF-κB [14], and Toll-like receptor [15] signaling pathways.